Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot (Phase I) Study of Weekly Docetaxel and Cetuximab Chemoradiation for Poor Risk Stage III Non-Small Cell Lung Cancer

NCT00288054 is registered in ClinicalTrials.gov with SWOG Cancer Research Network as lead sponsor.

NCT NCT00288054
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00288054 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot (Phase I) Study of Weekly Docetaxel and Cetuximab Chemoradiation for Poor Risk Stage III Non-Small Cell Lung Cancer
Lead sponsor
SWOG Cancer Research Network
Phase
Phase 1
Overall status
Terminated
Start date
April 30, 2006
Completion date
April 30, 2012
Enrollment
24 (actual)
Sites
77

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer